| Gordon F Gibbs, MD | |
|
115 E Riverwalk, Unit 200, Pueblo, CO 81003-3308 | |
| (719) 542-7891 | |
| Not Available |
| Full Name | Gordon F Gibbs |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 25 Years |
| Location | 115 E Riverwalk, Pueblo, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417929373 | NPI | - | NPPES |
| 08179263 | Medicaid | CO | |
| 852927200 | Medicaid | MN |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Corwin Med Ctr, Centura Health | Pueblo, CO | Hospital |
| Centura Health-st Thomas More Hospital | Canon city, CO | Hospital |
| Spanish Peaks Regional Health Center | Walsenburg, CO | Hospital |
| Morrill County Community Hospital | Bridgeport, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pueblo Radiological Group, P.c. | 5597661272 | 6 |
| Rocky Mountain Vein Institute Pllc | 8325181431 | 16 |
News Archive
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
In patients with non-small cell lung cancer, five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: (1) When can cure be declared with confidence and (2) for how long should follow-up examination be continued?
Both subjective and objective cognitive impairment are highly common among non-demented elderly Swedes, with an overall prevalence of 39 percent and 25 percent respectively, according to a nation-wide twin-study by researchers at the Aging Research Center of Karolinska Institutet, Sweden. The study confirms higher education as a major protective factor and stresses the importance of environmental aspects over genes in mild cognitive disorders in old age.
Given that phages are able to destroy bacteria, they are of particular interest to science. Basic researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin are especially interested in the tube used by phages to implant their DNA into bacteria.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A. Inc. today announced the filing of a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for a new indication for AMITIZA (lubiprostone) for the treatment of opioid-induced constipation (OIC) in patients with chronic, non-cancer pain.
› Verified 5 days ago
| Entity Name | Pueblo Radiological Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568444271 PECOS PAC ID: 5597661272 Enrollment ID: O20031211001035 |
News Archive
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
In patients with non-small cell lung cancer, five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: (1) When can cure be declared with confidence and (2) for how long should follow-up examination be continued?
Both subjective and objective cognitive impairment are highly common among non-demented elderly Swedes, with an overall prevalence of 39 percent and 25 percent respectively, according to a nation-wide twin-study by researchers at the Aging Research Center of Karolinska Institutet, Sweden. The study confirms higher education as a major protective factor and stresses the importance of environmental aspects over genes in mild cognitive disorders in old age.
Given that phages are able to destroy bacteria, they are of particular interest to science. Basic researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin are especially interested in the tube used by phages to implant their DNA into bacteria.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A. Inc. today announced the filing of a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for a new indication for AMITIZA (lubiprostone) for the treatment of opioid-induced constipation (OIC) in patients with chronic, non-cancer pain.
› Verified 5 days ago
| Entity Name | Rocky Mountain Vein Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457685398 PECOS PAC ID: 8325181431 Enrollment ID: O20100211000128 |
News Archive
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
In patients with non-small cell lung cancer, five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: (1) When can cure be declared with confidence and (2) for how long should follow-up examination be continued?
Both subjective and objective cognitive impairment are highly common among non-demented elderly Swedes, with an overall prevalence of 39 percent and 25 percent respectively, according to a nation-wide twin-study by researchers at the Aging Research Center of Karolinska Institutet, Sweden. The study confirms higher education as a major protective factor and stresses the importance of environmental aspects over genes in mild cognitive disorders in old age.
Given that phages are able to destroy bacteria, they are of particular interest to science. Basic researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin are especially interested in the tube used by phages to implant their DNA into bacteria.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A. Inc. today announced the filing of a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for a new indication for AMITIZA (lubiprostone) for the treatment of opioid-induced constipation (OIC) in patients with chronic, non-cancer pain.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gordon F Gibbs, MD Po Box 7702, Loveland, CO 80537-0702 Ph: (719) 543-8346 | Gordon F Gibbs, MD 115 E Riverwalk, Unit 200, Pueblo, CO 81003-3308 Ph: (719) 542-7891 |
News Archive
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
In patients with non-small cell lung cancer, five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: (1) When can cure be declared with confidence and (2) for how long should follow-up examination be continued?
Both subjective and objective cognitive impairment are highly common among non-demented elderly Swedes, with an overall prevalence of 39 percent and 25 percent respectively, according to a nation-wide twin-study by researchers at the Aging Research Center of Karolinska Institutet, Sweden. The study confirms higher education as a major protective factor and stresses the importance of environmental aspects over genes in mild cognitive disorders in old age.
Given that phages are able to destroy bacteria, they are of particular interest to science. Basic researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin are especially interested in the tube used by phages to implant their DNA into bacteria.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A. Inc. today announced the filing of a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for a new indication for AMITIZA (lubiprostone) for the treatment of opioid-induced constipation (OIC) in patients with chronic, non-cancer pain.
› Verified 5 days ago
Dr. Michael J Mccollum, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1008 Minnequa Ave, Pueblo, CO 81004 Phone: 719-542-7891 | |
Krynn Louis Stegelmeier, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1619 N Greenwood St, Pueblo, CO 81003 Phone: 719-542-2167 | |
Geoffrey Eric Johnson, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1008 Minnequa Ave, Pueblo, CO 81004 Phone: 719-557-5460 | |
Lisa T Cramer, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1619 N Greenwood St, Suite 103, Pueblo, CO 81003 Phone: 719-542-2167 Fax: 719-542-0320 | |
William J Bufkin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 124 W Pitkin Ave, Pueblo, CO 81004 Phone: 719-584-7410 Fax: 719-542-7019 | |
Dr. Anna-maria Alicia De Costa, MD, PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1008 Minnequa Ave, Pueblo, CO 81004 Phone: 719-557-5460 Fax: 719-557-4648 |